Learn about Long-Acting Injectable (LAI) Buprenorphine in this comprehensive medical lecture presented by Dr. Jeremy Hustead as part of the West Virginia Clinical and Translational Science Institute (WVCTSI) Project ECHO Substance Use Disorder series. Explore the latest developments, clinical applications, and treatment protocols for LAI Buprenorphine in addiction medicine, gaining valuable insights into this important medication-assisted treatment option for patients with opioid use disorder.
Long-Acting Injectable Buprenorphine for Substance Use Disorder Treatment
WVCTSI Project ECHO via YouTube
Overview
Syllabus
LAI Buprenorphine by Dr. Jeremy Hustead
Taught by
WVCTSI Project ECHO
Related Courses
-
AXL: Advanced Opioid Use Disorder X-waiver Team Learning Collaborative - Long-Term OUD Medication Management
-
AXL - Opioid Use Disorder X-waiver Team Learning Collaborative - Pain Treatment in Substance Use Disorders
-
Emergency Care for Opioid Use Disorder
-
AXL: Advanced Opioid Use Disorder X-waiver Team Learning Collaborative MAT and Telemedicine
-
AXL: Advanced Opioid Use Disorder X-waiver Team Learning Collaborative - Treating Alcohol Use Disorder in Patients Receiving Medication for OUD
-
AXL: Advanced Opioid Use Disorder X-waiver Team Learning Collaborative - Buprenorphine & Diversion: The Vermont Regulatory Environment.
